BFRA

Biofrontera AG

Price

return (12m)

0.00%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

BFRA price

Biofrontera

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BFRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BFRA

Valuation

P/E

0.00

Sector -4.15

Industry -4.15

P/BV

0.00

Sector 2.06

Industry 2.06

P/Revenue (PSR)

0.00

Sector -4.16

Industry -4.16

EV/EBITDA

5.79

Sector -241.86

Industry -241.86

EV/EBIT

5.79

Sector -671.75

Industry -671.75

P/EBITDA

0.00

Sector -4.30

Industry -4.30

P/EBIT

0.00

Sector -4.35

Industry -4.35

P/Total Assets

0.00

Sector 1.46

Industry 1.46

P/Net Current Assets

Sector -12.67

Industry -12.67

P/Working Capital

Sector -12.58

Industry -12.58

EPS

-999,999.99

Sector -2.19

Industry -2.19

BVPS

181,659.48

Sector 1.92

Industry 1.92

Efficiency

Gross Margin

89.44%

Sector 36.44%

Industry 36.44%

EBITDA Margin

-92.79%

Sector -16,748.51%

Industry -16,748.51%

EBIT Margin

-92.79%

Sector -4,256,846.44%

Industry -4,256,846.44%

Operating Margin

2.78%

Sector -38.78%

Industry -38.78%

Net Profit Margins

-14.76%

Sector -39.93%

Industry -39.93%

Asset Turnover

0.08

Sector 0.03

Industry 0.03

Profitability

ROE

-893.55%

Sector -67.01%

Industry -67.01%

ROA

-205.16%

Sector -66.28%

Industry -66.28%

ROIC

Sector -2,917.75%

Industry -2,917.75%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.90

Industry 2.90

Net Debt / EBITDA

5.79

Sector -12,252,405.04

Industry -12,252,405.04

Net Debt / EBIT

5.79

Sector -3.79

Industry -3.79

Net Debt / Equity

-1.82

Sector -33,290.93

Industry -33,290.93

Gross Debt / Equity

0.13

Sector 0.00

Industry 0.00

Equity/Assets

0.23

Sector 0.42

Industry 0.42

Liabilities/Assets

0.77

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

64.87%

Sector -

Industry -

5Y Earnings CAGR

23.43%

Sector -

Industry -

Fundamentals BFRA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BFRA Biofrontera AG	$0.00	-	0.00%	0.00	0.00	-893.55%	-14.76%
AZN AstraZeneca PLC	$204.64	53.45%	1.89%	25.20	5.52	21.93%	17.19%
JNJ Johnson & Johnson	$240.16	62.69%	2.08%	28.83	0.00	-%	21.48%
NBIX Neurocrine Biosciences Inc.	$130.81	43.95%	0.00%	25.46	5.00	19.62%	21.55%
ABEO Abeona Therapeutics Inc.	$5.19	12.83%	0.00%	6.09	2.78	45.63%	100.00%
PFE Pfizer Inc.	$27.11	32.71%	6.97%	18.76	1.55	8.29%	11.83%
ABBV AbbVie Inc.	$210.26	25.08%	2.61%	125.53	-69.01	-54.98%	5.79%
ABUS Arbutus Biopharma Corporation	$4.35	38.54%	0.00%	5.66	3.50	61.77%	83.94%
ACAD ACADIA Pharmaceuticals Inc.	$22.02	51.03%	0.00%	11.55	3.48	30.10%	34.30%
ADMA ADMA Biologics Inc.	$10.49	-45.93%	0.00%	12.58	5.33	42.37%	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BFRA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/25/2021	03/04/2021	0.10390000
Dividends	08/17/2020	08/24/2020	0.02360000
Dividends	03/19/2020	03/30/2020	0.02210000

ABOUT Biofrontera

Biofrontera AG

Average Investor10 user rating

4.0 (0 people)

States of America

29 years

Founded: 1997

2018

Time since IPO - 8 years

149

Employees

Biofrontera AG (States of America) is listed on the Nasdaq and has a market capitalization of $55.02 million, with shareholders equity totaling $5.15 trillion.

The company employs approximately 149 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, Biofrontera AG reported $311.95 trillion in revenue, generating net income of $-46.03 trillion.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BFRA.

Market cap

$55.02 million

Net worth

$5.15 trillion

$5,151,625,168,378.40

Assets

$22.44 trillion

$22,437,037,247,130.00

Total Shares Outstanding

28.36 million

28,358,000

Average Daily Trading Volume

$4.98 Thousand

$4,977.78

Sector

Healthcare

Industry

Biotecnologia

BFRA

BFRA revenue and profits

Financial Results BFRA

DRAG THE FRAME TO SEE MORE DATA

BFRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

MCK - McKesson

$862.96 22,54% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$214.95 38,63% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$240.16 47,25% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$119.96 46,43% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

AZN - AstraZeneca

$204.64 40,78% (12M)

P/E

25.20

1.89%

ROE

21.93%

P/BV

5.52

ABBV - AbbVie

$210.26 15,08% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$39.32 --40,26% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14

PFE - Pfizer

$27.11 17,37% (12M)

P/E

18.76

6.97%

ROE

8.29%

P/BV

1.55